跳至主要内容
临床试验/NCT03011931
NCT03011931已完成早期 1 期

Simvastatin Metabolism as a Test for Celiac Disease Activity

Entero Therapeutics1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年3月最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Compare simvastatin metabolism with intestinal biopsies

研究概览

简要总结

To study the correlation between simvastatin metabolism by the enterocyte and the histologic state of the intestine in treated celiac disease.

详细描述

A cross sectional design incorporating subjects with active celiac disease and healed celiac disease (based on clinically-obtained biopsies); and healthy individuals.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Gluten-free diet for at least 1 year
  • Clinical endoscopy within the past month
  • Biopsies must show no villous atrophy or villous blunting
  • Villous height to crypt depth (VHCD) ratio measurement should be 2.5:1 or greater

排除标准

  • 1st degree relative with Celiac Disease
  • Positive tTG IgA, already on simvastatin or statin agent
  • Unable to stop non-steroidal or anti-inflammatory drugs
  • Prior history of GI surgery other than appendectomy or cholecystectomy
  • Taking drugs know to inhibit or activate CYP3A4
  • Unable to avoid food known to inhibit CYP3A4
  • History of a reaction to statin drugs in the past
  • Pregnant or nursing women

研究组 & 干预措施

Simvastatin

Experimental

Simvastatin tablet, 20 mg, one time by mouth

干预措施: Simvastatin (Drug)

结局指标

主要结局

Compare simvastatin metabolism with intestinal biopsies

时间窗: Within one month of visit

次要结局

  • DNA sampling(Prior to administration of simvastatin)
  • Villous height and crypt depth(Within 1 month of visit)
  • Dietary interview(At initial visit)
  • Urinalysis(Prior to administration of simvastatin and at the 3-hour mark)
  • Serologic testing(Prior to administration of simvastatin)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Simvastatin Metabolism as a Test for CD Activity... | 临床试验